Related Experiment Video

Updated: Jul 3, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

The natural course of HCV infection and the need for treatment

Savino Bruno1, Corinna Facciotto

  • 1Department of Internal Medicine, Liver Unit, Azienda Ospedaliera Fatebenefratelli e Oftalmico, Milano, Italy. savino.bruno@fbf.milano.it

Annals of Hepatology
|July 16, 2008
PubMed

Insights

Hepatitis C infection is a major cause of chronic liver disease. Antiviral therapy has improved long-term outcomes for patients with sustained virological response.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Viral Hepatitis

Background:

  • Hepatitis C infection is a leading cause of chronic liver disease, cirrhosis, and hepatocellular carcinoma globally.
  • Over 150 million people are infected worldwide, yet the disease's natural history is complex due to asymptomatic acute phases and indolent progression.
  • Disease progression is influenced by host, viral, and environmental factors, leading to heterogeneous complication rates.

Purpose of the Study:

  • To explore the complex natural history of hepatitis C infection.
  • To understand the factors influencing disease progression and complications.
  • To evaluate the impact of antiviral therapy on long-term outcomes.

Main Methods:

  • Analysis of data from retrospective, prospective, and retrospective-prospective cohort studies.
  • Assessment of host, viral, and environmental variables affecting disease progression.
  • Evaluation of outcomes in patients treated with antiviral therapy, particularly interferon.

Main Results:

  • The natural history of hepatitis C is challenging to assess due to its asymptomatic onset and slow progression.
  • Heterogeneity in complication rates observed across different study methodologies highlights the complexity.
  • Effective antiviral therapy, leading to sustained virological response, significantly improves patient survival.

Conclusions:

  • Hepatitis C poses a significant global health challenge due to its complex and variable disease course.
  • Understanding the multifactorial influences on hepatitis C progression is crucial for patient management.
  • Antiviral therapies represent a major advancement, dramatically improving long-term outcomes and survival rates for infected individuals.

More Related Videos

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Genital Herpes01:23

Genital Herpes

Genital herpes is a sexually transmitted infection primarily caused by herpes simplex virus type 2 (HSV-2), though herpes simplex virus type 1 (HSV-1) is increasingly implicated in genital infections, particularly among younger populations. Transmission occurs mainly through sexual contact, with asymptomatic viral shedding serving as a major route of spread. This characteristic makes HSV-2 difficult to control at a population level, as individuals may unknowingly transmit the virus even in the...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...